Angiosoma, Inc.
Get Full AccessDescription
- AngioSoma, Inc. is a publicly traded (OTCQB:SOAN) clinical stage biopharmaceutical company focused on improving the effectiveness of current standard-of-care treatments, especially related to endovascular interventions in the treatment of peripheral artery disease (PAD). Our lead pharmaceutical product Liprostin, a treatment for PAD, has successfully completed FDA Phase I and three Phase II clinical trials, and we are in discussions with several contract research organizations for rapid completion of our U.S. Food and Drug Administration (FDA) approved protocol for Phase III with submission of our new drug application for marketing in the U.S. and its territories.
-
Headquarters:14001 Walden Road Suite 600, Montgomery, Texas, United States
More -
Phone Number: +1 281-381-5334
-
Website: https://www.angiosoma.com
-
Employees:2
-
Revenue:$0 - 1M
-
Legal Name:Angiosoma, Inc.
-
Angiosoma, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Angiosoma, Inc.
-
Where are Angiosoma, Inc.'s Headquarters?
Angiosoma, Inc.'s Headquarters are in 14001 Walden Road Suite 600,Montgomery,Texas,United States
-
What is Angiosoma, Inc.'s phone number?
Angiosoma, Inc.'s phone number is +1 281-381-5334
-
What is Angiosoma, Inc.'s official website?
Angiosoma, Inc.'s official website is https://www.angiosoma.com
-
What is Angiosoma, Inc.'s Revenue?
Angiosoma, Inc.'s revenue is $0 - 1M
-
What is Angiosoma, Inc.'s NAICS code?
Angiosoma, Inc.'s NAICS code is 325412
-
How many employees are working in Angiosoma, Inc.
Angiosoma, Inc. has 2 employees
-
What is Angiosoma, Inc.'s Industry?
Angiosoma, Inc. is in the industry of Pharmaceuticals
-
Who is Angiosoma, Inc.'s Chairman Emeritus?
Angiosoma, Inc.'s Chairman Emeritus is David Summers

